EXAGEN INC. Stockholders Equity

Quick Answer

EXAGEN INC. reported Stockholders Equity of $17.45 million for fiscal year 2025.

EXAGEN INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $17.45M +82.9%
2024 $9.54M -58.0%
2023 $22.69M -46.6%
2022 $42.46M -50.0%
2021 $84.94M +103.0%
2020 $41.84M -24.8%
2019 $55.66M +149.7%
2018 -$111.97M -15.8%
2017 -$96.68M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 $18.14M +41.0% -13.8%
June 30, 2025 $21.03M +19.6% +228.5%
March 31, 2025 $6.40M -68.0% -32.9%
December 31, 2024 $9.54M -58.0% -25.9%
September 30, 2024 $12.87M -53.2% -26.8%
June 30, 2024 $17.59M -44.9% -12.0%
March 31, 2024 $19.99M -44.4% -11.9%
December 31, 2023 $22.69M -46.6% -17.5%
  • EXAGEN INC. showed an increase of +82.9% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2017–2025 period, EXAGEN INC.’s stockholders equity has grown by 118.0% (from -$96.68 million to $17.45 million).
  • The most recent figure is from EXAGEN INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment